Evidence map›Paper›PMID 25950958›Full record

ArticleMethods in enzymology2015

A Novel Screening Approach for Optimal and Functional Fusion of T4 Lysozyme in GPCRs.

Elizabeth Mathew, Mark E Dumont

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elizabeth MathewDepartment of Biochemistry and Biophysics, P.O. Box 712, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Mark E DumontDepartment of Biochemistry and Biophysics, P.O. Box 712, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. Electronic address: mark_dumont@urmc.rochester.edu.
University of Rochester · US

Funding

Multi-Level Optimization of Membrane Proteins for CrystallographyU54GM094611 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI DUMONT, MARK E. · 2010 to 2014
$6.3M
Genetic Optimization of Membrane Protein Production for CrystallizationR01GM084083 · NIGMS · UNIVERSITY OF ROCHESTER · PI DUMONT, MARK E. · 2009 to 2012
$1.3M
NIGMS NIH HHS R01 GM084083NIGMS NIH HHS R01GM084083NIGMS NIH HHS U54GM09461NIGMS NIH HHS U54 GM094611
6 · The paper itself

Abstract

Determination of high-resolution, three-dimensional structures of transmembrane proteins (TMPs) has, in many cases, only been accomplished through the use of stabilized variant forms of the proteins being studied. For the important G protein-coupled receptor superfamily, this has most often been achieved by inserting a stable soluble protein, such as T4 lysozyme (T4L), in an internal loop of a receptor. However, creation of such fusion proteins generally results in loss of the ability of receptors to activate their cognate cytoplasmic G proteins. Furthermore, the criteria for designing fusions that minimally perturb receptor structure are not well established. We describe here a method for creating a library of receptor variants containing T4L inserted into an internal loop at varying positions and as replacements for varying amounts of the original receptor sequence. We also describe methods for screening for variants displaying maximal expression levels, ligand binding capacity, and signaling function. When applied to the yeast α-factor receptor, Ste2p, this approach allowed recovery of well-expressed receptor variants containing internally fused T4L that retained nearly normal signaling function. The approach we describe can be readily adapted to creation of stabilized fusions of other TMPs expressed in yeast or other expression systems.

Indexed as

Bacteriophage T4Gene ExpressionMuramidasePlasmidsProtein ConformationReceptors, G-Protein-CoupledReceptors, Mating FactorRecombinant Fusion ProteinsSaccharomyces cerevisiaeSolubilityViral ProteinsMuramidaseReceptors, G-Protein-CoupledReceptors, Mating FactorRecombinant Fusion ProteinsViral ProteinsG protein-coupled receptorsMembrane proteinsPheromone receptorProtein stabilityRandom screeningX-ray crystallographyYeast genetics

Identifiers

PMID25950958
PMCPMC5094897
OpenAlexW2398139648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.